[시장보고서]올리고 합성 시장 : 분석 및 예측(2019-2030년)

올리고 합성 시장 : 분석 및 예측(2019-2030년)

Global Oligo Synthesis Market Report, History and Forecast 2019-2030

상품코드 : 1453638

리서치사 : QYResearch

발행일 : 2024년 03월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

US $ 3,350

￦ 4,970,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,025

￦ 7,455,000

PDF (Multi User License)

PDF, Excel 보고서를 동일 기업내 10명까지 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.

US $ 6,700

￦ 9,940,000

PDF (Enterprise User License)

PDF, Excel, Word 보고서를 동일 기업내 모든 구성원이 이용하실 수 있는 라이선스입니다. 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF, Excel, Word 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 올리고 합성 시장 규모는 2023년 6억 4,451만 달러에서 예측 기간 동안 11.59%의 CAGR로 성장하여 2030년에는 13억 5,114만 달러 규모에 이를 것으로 예상됩니다.

북미 시장은 2023년 3억 4,444만 달러에서 같은 기간 동안 11.58%의 CAGR로 성장하여 2030년에는 7억 1,825만 달러에 달할 것으로 예상됩니다. 아시아태평양 시장은 2023년 1억 6,164만 달러에서 12.10%의 CAGR로 성장하여 2030년에는 3억 5,036만 달러 규모로 성장할 것으로 예상됩니다. 유럽 시장은 2023년 9,648만 달러에서 11.04%의 CAGR로 성장하여 2030년에는 1억 9,484만 달러에 달할 것으로 예상됩니다.

세계 올리고 합성 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 시장 규모 추이 및 예측, 유형별·용도별 분석, 지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

Thermo Fisher Scientific
Azenta Life Sciences
Genscript
Abace Biotechnology
Tsingke
Guangzhou RiboBio
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Biosune
Integrated DNA Technologies(IDT)
Cusabio
Macrogen
Synbio Technologies
Eurogentec
BBI Life Sciences
TriLink BioTechnologies
Aurigene Pharmaceutical Services
Merck

제6장 북미

시장 규모 추정과 예측
미국
캐나다

제7장 유럽

시장 규모 추정과 예측
독일
영국
프랑스
러시아
이탈리아
기타

제8장 아시아태평양

시장 규모 추정과 예측
중국
일본
한국
인도
동남아시아
기타

제9장 라틴아메리카

시장 규모 추정과 예측
멕시코
브라질
기타

제10장 중동 및 아프리카

시장 규모 추정과 예측
터키
사우디아라비아
기타

제11장 올리고 합성 : 시장 역학

업계 동향
시장 성장 촉진요인
시장 과제
시장 성장 억제요인

제12장 조사 결과와 결론

제13장 조사 방법과 정보 출처

ksm

영문 목차

영문목차

The global market for Oligo Synthesis estimated was at US$ 644.51 million in the year 2023, is projected to reach a revised size of US$ 1351.14 million by 2030, growing at a CAGR of 11.59% during the forecast period 2024-2030.

North American market for Oligo Synthesis was valued at $ 344.44 million in 2023 and will reach $ 718.25 million by 2030, at a CAGR of 11.58% during the forecast period of 2024 through 2030.

Asia-Pacific market for Oligo Synthesis was valued at $ 161.64 million in 2023 and will reach $ 350.36 million by 2030, at a CAGR of 12.10% during the forecast period of 2024 through 2030.

Europe market for Oligo Synthesis was valued at $ 96.48 million in 2023 and will reach $ 194.84 million by 2030, at a CAGR of 11.04% during the forecast period of 2024 through 2030.

This report aims to provide a comprehensive presentation of the global market for Oligo Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligo Synthesis.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligo Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Oligo Synthesis segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2019-2024, 2025-2030), considering 2023 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

Thermo Fisher Scientific
Azenta Life Sciences
Genscript
Abace Biotechnology
Tsingke
Guangzhou RiboBio
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Biosune
Integrated DNA Technologies (IDT)
Cusabio
Macrogen
Synbio Technologies
Eurogentec
BBI Life Sciences
TriLink BioTechnologies
Aurigene Pharmaceutical Services
Merck

Segment by Type

Common Primer Synthesis
Modified Primer Synthesis

Segment by Application

Biotech Company
Academic Scientific Research Institution

By Region

North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia

Chapter Outline

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of Oligo Synthesis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion

1 Market Overview of Oligo Synthesis

1.1 Oligo Synthesis Market Overview
- 1.1.1 Oligo Synthesis Product Scope
- 1.1.2 Oligo Synthesis Market Status and Outlook
1.2 Global Oligo Synthesis Market Size Overview by Region 2019 VS 2023 VS 2030
1.3 Global Oligo Synthesis Market Size by Region (2019-2030)
- 1.3.1 Global Oligo Synthesis Historic Market Size by Region (2019-2024)
- 1.3.2 Global Oligo Synthesis Market Size Forecast by Region (2025-2030)
1.4 Key Regions Oligo Synthesis Market Size (2019-2030)
- 1.4.1 North America Oligo Synthesis Market Size (2019-2030)
- 1.4.2 Europe Oligo Synthesis Market Size (2019-2030)
- 1.4.3 Asia-Pacific Oligo Synthesis Market Size (2019-2030)
- 1.4.4 Latin America Oligo Synthesis Market Size (2019-2030)
- 1.4.5 Middle East & Africa Oligo Synthesis Market Size (2019-2030)

2 Oligo Synthesis Market by Type

2.1 Introduction
- 2.1.1 Common Primer Synthesis
- 2.1.2 Modified Primer Synthesis
2.2 Global Oligo Synthesis Market Size by Type: 2019 VS 2023 VS 2030
- 2.2.1 Global Oligo Synthesis Historic Market Size by Type (2019-2024)
- 2.2.2 Global Oligo Synthesis Forecasted Market Size by Type (2025-2030)
2.3 Key Regions Market Size by Type
- 2.3.1 North America Oligo Synthesis Revenue Breakdown by Type (2019-2030)
- 2.3.2 Europe Oligo Synthesis Revenue Breakdown by Type (2019-2030)
- 2.3.3 Asia-Pacific Oligo Synthesis Revenue Breakdown by Type (2019-2030)
- 2.3.4 Latin America Oligo Synthesis Revenue Breakdown by Type (2019-2030)
- 2.3.5 Middle East and Africa Oligo Synthesis Revenue Breakdown by Type (2019-2030)

3 Oligo Synthesis Market Overview by Application

3.1 Introduction
- 3.1.1 Biotech Company
- 3.1.2 Academic Scientific Research Institution
3.2 Global Oligo Synthesis Market Size by Application: 2019 VS 2023 VS 2030
- 3.2.1 Global Oligo Synthesis Historic Revenue by Application (2019-2024)
- 3.2.2 Global Oligo Synthesis Forecasted Revenue by Application (2025-2030)
3.3 Key Regions Market Size by Application
- 3.3.1 North America Oligo Synthesis Revenue Breakdown by Application (2019-2030)
- 3.3.2 Europe Oligo Synthesis Revenue Breakdown by Application (2019-2030)
- 3.3.3 Asia-Pacific Oligo Synthesis Revenue Breakdown by Application (2019-2030)
- 3.3.4 Latin America Oligo Synthesis Revenue Breakdown by Application (2019-2030)
- 3.3.5 Middle East and Africa Oligo Synthesis Revenue Breakdown by Application (2019-2030)

4 Oligo Synthesis Competition Analysis by Players

4.1 Global Oligo Synthesis Market Size by Players (2019-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligo Synthesis as of 2023)
4.3 Global Key Players of Oligo Synthesis Head office and Area Served
4.4 Global Key Players of Oligo Synthesis, Product and Application
4.5 Global Key Players of Oligo Synthesis, Date of Established
4.6 Competitive Status
- 4.6.1 Oligo Synthesis Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Thermo Fisher Scientific
- 5.1.1 Thermo Fisher Scientific Profile
- 5.1.2 Thermo Fisher Scientific Main Business
- 5.1.3 Thermo Fisher Scientific Oligo Synthesis Products, Services and Solutions
- 5.1.4 Thermo Fisher Scientific Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Azenta Life Sciences
- 5.2.1 Azenta Life Sciences Profile
- 5.2.2 Azenta Life Sciences Main Business
- 5.2.3 Azenta Life Sciences Oligo Synthesis Products, Services and Solutions
- 5.2.4 Azenta Life Sciences Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.2.5 Azenta Life Sciences Recent Developments
5.3 Genscript
- 5.3.1 Genscript Profile
- 5.3.2 Genscript Main Business
- 5.3.3 Genscript Oligo Synthesis Products, Services and Solutions
- 5.3.4 Genscript Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.3.5 Genscript Recent Developments
5.4 Abace Biotechnology
- 5.4.1 Abace Biotechnology Profile
- 5.4.2 Abace Biotechnology Main Business
- 5.4.3 Abace Biotechnology Oligo Synthesis Products, Services and Solutions
- 5.4.4 Abace Biotechnology Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.5 Tsingke
- 5.5.1 Tsingke Profile
- 5.5.2 Tsingke Main Business
- 5.5.3 Tsingke Oligo Synthesis Products, Services and Solutions
- 5.5.4 Tsingke Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.6 Guangzhou RiboBio
- 5.6.1 Guangzhou RiboBio Profile
- 5.6.2 Guangzhou RiboBio Main Business
- 5.6.3 Guangzhou RiboBio Oligo Synthesis Products, Services and Solutions
- 5.6.4 Guangzhou RiboBio Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.6.5 Guangzhou RiboBio Recent Developments
5.7 Atantares
- 5.7.1 Atantares Profile
- 5.7.2 Atantares Main Business
- 5.7.3 Atantares Oligo Synthesis Products, Services and Solutions
- 5.7.4 Atantares Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.7.5 Atantares Recent Developments
5.8 Wuhan GeneCreate Biological Engineering
- 5.8.1 Wuhan GeneCreate Biological Engineering Profile
- 5.8.2 Wuhan GeneCreate Biological Engineering Main Business
- 5.8.3 Wuhan GeneCreate Biological Engineering Oligo Synthesis Products, Services and Solutions
- 5.8.4 Wuhan GeneCreate Biological Engineering Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.9 Beyotime
- 5.9.1 Beyotime Profile
- 5.9.2 Beyotime Main Business
- 5.9.3 Beyotime Oligo Synthesis Products, Services and Solutions
- 5.9.4 Beyotime Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.10 General Biol
- 5.10.1 General Biol Profile
- 5.10.2 General Biol Main Business
- 5.10.3 General Biol Oligo Synthesis Products, Services and Solutions
- 5.10.4 General Biol Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.11 Biosune
- 5.11.1 Biosune Profile
- 5.11.2 Biosune Main Business
- 5.11.3 Biosune Oligo Synthesis Products, Services and Solutions
- 5.11.4 Biosune Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.12 Integrated DNA Technologies (IDT)
- 5.12.1 Integrated DNA Technologies (IDT) Profile
- 5.12.2 Integrated DNA Technologies (IDT) Main Business
- 5.12.3 Integrated DNA Technologies (IDT) Oligo Synthesis Products, Services and Solutions
- 5.12.4 Integrated DNA Technologies (IDT) Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.12.5 Integrated DNA Technologies (IDT) Recent Developments
5.13 Cusabio
- 5.13.1 Cusabio Profile
- 5.13.2 Cusabio Main Business
- 5.13.3 Cusabio Oligo Synthesis Products, Services and Solutions
- 5.13.4 Cusabio Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.14 Macrogen
- 5.14.1 Macrogen Profile
- 5.14.2 Macrogen Main Business
- 5.14.3 Macrogen Oligo Synthesis Products, Services and Solutions
- 5.14.4 Macrogen Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.14.5 Macrogen Recent Developments
5.15 Synbio Technologies
- 5.15.1 Synbio Technologies Profile
- 5.15.2 Synbio Technologies Main Business
- 5.15.3 Synbio Technologies Oligo Synthesis Products, Services and Solutions
- 5.15.4 Synbio Technologies Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.16 Eurogentec
- 5.16.1 Eurogentec Profile
- 5.16.2 Eurogentec Main Business
- 5.16.3 Eurogentec Oligo Synthesis Products, Services and Solutions
- 5.16.4 Eurogentec Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.17 BBI Life Sciences
- 5.17.1 BBI Life Sciences Profile
- 5.17.2 BBI Life Sciences Main Business
- 5.17.3 BBI Life Sciences Oligo Synthesis Products, Services and Solutions
- 5.17.4 BBI Life Sciences Oligo Synthesis Revenue (US$ Million) & (2019-2024)
5.18 TriLink BioTechnologies
- 5.18.1 TriLink BioTechnologies Profile
- 5.18.2 TriLink BioTechnologies Main Business
- 5.18.3 TriLink BioTechnologies Oligo Synthesis Products, Services and Solutions
- 5.18.4 TriLink BioTechnologies Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.18.5 TriLink BioTechnologies Recent Developments
5.19 Aurigene Pharmaceutical Services
- 5.19.1 Aurigene Pharmaceutical Services Profile
- 5.19.2 Aurigene Pharmaceutical Services Main Business
- 5.19.3 Aurigene Pharmaceutical Services Oligo Synthesis Products, Services and Solutions
- 5.19.4 Aurigene Pharmaceutical Services Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.19.5 Aurigene Pharmaceutical Services Recent Developments
5.20 Merck
- 5.20.1 Merck Profile
- 5.20.2 Merck Main Business
- 5.20.3 Merck Oligo Synthesis Products, Services and Solutions
- 5.20.4 Merck Oligo Synthesis Revenue (US$ Million) & (2019-2024)
- 5.20.5 Merck Recent Developments

6 North America

6.1 North America Oligo Synthesis Market Size by Country (2019-2030)
6.2 United States
6.3 Canada

7 Europe

7.1 Europe Oligo Synthesis Market Size by Country (2019-2030)
7.2 Germany
7.3 U.K.
7.4 France
7.5 Russia
7.6 Italy
7.7 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Oligo Synthesis Market Size by Region (2019-2030)
8.2 China
8.3 Japan
8.4 South Korea
8.5 India
8.6 Southeast Asia
8.7 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Oligo Synthesis Market Size by Country (2019-2030)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Oligo Synthesis Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 Rest of Middle East & Africa

11 Oligo Synthesis Market Dynamics

11.1 Oligo Synthesis Industry Trends
11.2 Oligo Synthesis Market Drivers
11.3 Oligo Synthesis Market Challenges
11.4 Oligo Synthesis Market Restraints

12 Research Finding/Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer